Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Validity of the diagnosis of pneumonia in hospitalised patients with COPD.

Finney LJ, Padmanaban V, Todd S, Ahmed N, Elkin SL, Mallia P.

ERJ Open Res. 2019 Jun 24;5(2). pii: 00031-2019. doi: 10.1183/23120541.00031-2019. eCollection 2019 Apr.

2.

Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations.

Calderazzo MA, Trujillo-Torralbo MB, Finney LJ, Singanayagam A, Bakhsoliani E, Padmanaban V, Kebadze T, Aniscenko J, Elkin SL, Johnston SL, Mallia P.

Int J Chron Obstruct Pulmon Dis. 2019 Apr 10;14:823-832. doi: 10.2147/COPD.S191946. eCollection 2019.

3.

WASP (write a scientific paper): The ethical stages of publishing a research paper.

Mallia P.

Saudi J Anaesth. 2019 Apr;13(Suppl 1):S44-S47. doi: 10.4103/sja.SJA_675_18. Review.

4.

Lesson of the month 2: A case of nitrous oxide-induced pancytopenia.

Norris F, Mallia P.

Clin Med (Lond). 2019 Mar;19(2):129-130. doi: 10.7861/clinmedicine.19-2-129.

5.

Comparative Metabolomic Sampling of Upper and Lower Airways by Four Different Methods to Identify Biochemicals That May Support Bacterial Growth.

Farne H, Groves HT, Gill SK, Stokes I, McCulloch S, Karoly E, Trujillo-Torralbo MB, Johnston SL, Mallia P, Tregoning JS.

Front Cell Infect Microbiol. 2018 Dec 18;8:432. doi: 10.3389/fcimb.2018.00432. eCollection 2018.

6.

Modulating airway glucose to reduce respiratory infections.

Tregoning JS, Mallia P.

Expert Rev Respir Med. 2019 Feb;13(2):121-124. doi: 10.1080/17476348.2019.1563487. Epub 2019 Jan 7. No abstract available.

PMID:
30582387
7.

Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease.

Finney LJ, Belchamber KBR, Fenwick PS, Kemp SV, Edwards MR, Mallia P, Donaldson G, Johnston SL, Donnelly LE, Wedzicha JA.

Am J Respir Crit Care Med. 2019 Jun 15;199(12):1496-1507. doi: 10.1164/rccm.201806-1095OC.

PMID:
30562053
8.

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.

Singanayagam A, Glanville N, Girkin JL, Ching YM, Marcellini A, Porter JD, Toussaint M, Walton RP, Finney LJ, Aniscenko J, Zhu J, Trujillo-Torralbo MB, Calderazzo MA, Grainge C, Loo SL, Veerati PC, Pathinayake PS, Nichol KS, Reid AT, James PL, Solari R, Wark PAB, Knight DA, Moffatt MF, Cookson WO, Edwards MR, Mallia P, Bartlett NW, Johnston SL.

Nat Commun. 2018 Jun 8;9(1):2229. doi: 10.1038/s41467-018-04574-1.

9.

WASP (Write a Scientific Paper): Ethics approval for a research study (1).

Mallia P.

Early Hum Dev. 2018 Sep;124:46-48. doi: 10.1016/j.earlhumdev.2018.04.022. Epub 2018 Jun 4.

PMID:
29880303
10.

WASP (Write a Scientific Paper): The right to privacy.

Mallia P.

Early Hum Dev. 2018 Sep;124:58-61. doi: 10.1016/j.earlhumdev.2018.04.026. Epub 2018 May 10.

PMID:
29753537
11.

WASP (Write a Scientific Paper): Recruitment for research.

Mallia P.

Early Hum Dev. 2018 Sep;124:52-53. doi: 10.1016/j.earlhumdev.2018.04.024. Epub 2018 May 3.

PMID:
29731263
12.

WASP (Write a Scientific Paper): Ethics approval for a research study (2).

Mallia P.

Early Hum Dev. 2018 Sep;124:49-51. doi: 10.1016/j.earlhumdev.2018.04.023. Epub 2018 May 4.

PMID:
29731261
13.

WASP (Write a Scientific Paper): Informed consent in research.

Mallia P.

Early Hum Dev. 2018 Sep;124:54-57. doi: 10.1016/j.earlhumdev.2018.04.025. Epub 2018 May 3.

PMID:
29731260
14.

WASP (Write a Scientific Paper): Special cases of selective non-treatment and/or DNR.

Mallia P.

Early Hum Dev. 2018 Sep;124:62-64. doi: 10.1016/j.earlhumdev.2018.04.027. Epub 2018 May 3.

PMID:
29729816
15.

Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations.

Zhu J, Message SD, Mallia P, Kebadze T, Contoli M, Ward CK, Barnathan ES, Mascelli MA, Kon OM, Papi A, Stanciu LA, Edwards MR, Jeffery PK, Johnston SL.

J Allergy Clin Immunol. 2019 Jan;143(1):114-125.e4. doi: 10.1016/j.jaci.2018.04.003. Epub 2018 Apr 24.

16.

Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.

Mallia P, Webber J, Gill SK, Trujillo-Torralbo MB, Calderazzo MA, Finney L, Bakhsoliani E, Farne H, Singanayagam A, Footitt J, Hewitt R, Kebadze T, Aniscenko J, Padmanaban V, Molyneaux PL, Adcock IM, Barnes PJ, Ito K, Elkin SL, Kon OM, Cookson WO, Moffat MF, Johnston SL, Tregoning JS.

J Allergy Clin Immunol. 2018 Sep;142(3):815-823.e6. doi: 10.1016/j.jaci.2017.10.017. Epub 2018 Jan 5.

17.

Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma.

Upton N, Jackson DJ, Nikonova AA, Hingley-Wilson S, Khaitov M, Del Rosario A, Traub S, Trujillo-Torralbo MB, Habibi M, Elkin SL, Kon OM, Edwards MR, Mallia P, Footitt J, Macintyre J, Stanciu LA, Johnston SL, Sykes A.

PLoS One. 2017 Aug 31;12(8):e0183864. doi: 10.1371/journal.pone.0183864. eCollection 2017.

18.

A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13).

Hansel TT, Tunstall T, Trujillo-Torralbo MB, Shamji B, Del-Rosario A, Dhariwal J, Kirk PDW, Stumpf MPH, Koopmann J, Telcian A, Aniscenko J, Gogsadze L, Bakhsoliani E, Stanciu L, Bartlett N, Edwards M, Walton R, Mallia P, Hunt TM, Hunt TL, Hunt DG, Westwick J, Edwards M, Kon OM, Jackson DJ, Johnston SL.

EBioMedicine. 2017 May;19:128-138. doi: 10.1016/j.ebiom.2017.03.033. Epub 2017 Mar 28.

19.

Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro.

Telcian AG, Zdrenghea MT, Edwards MR, Laza-Stanca V, Mallia P, Johnston SL, Stanciu LA.

Antiviral Res. 2017 Jan;137:93-101. doi: 10.1016/j.antiviral.2016.11.004. Epub 2016 Nov 10.

20.

A randomised, double-blind, placebo-controlled study to evaluate the efficacy of oral azithromycin as a supplement to standard care for adult patients with acute exacerbations of asthma (the AZALEA trial).

Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, Mallia P, Wong E, Corrigan C, Higgins B, Ind P, Singh D, Thomson N, Ashby D, Chauhan A.

Southampton (UK): NIHR Journals Library; 2016 Oct.

21.

Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical Trial.

Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, Mallia P, Wong E, Corrigan C, Higgins B, Ind P, Singh D, Thomson NC, Ashby D, Chauhan A; AZALEA Trial Team.

JAMA Intern Med. 2016 Nov 1;176(11):1630-1637. doi: 10.1001/jamainternmed.2016.5664. Erratum in: JAMA Intern Med. 2018 Jul 1;178(7):1003.

22.

Raised interferon-β, type 3 interferon and interferon-stimulated genes - evidence of innate immune activation in neutrophilic asthma.

da Silva J, Hilzendeger C, Moermans C, Schleich F, Henket M, Kebadze T, Mallia P, Edwards MR, Johnston SL, Louis R.

Clin Exp Allergy. 2017 Mar;47(3):313-323. doi: 10.1111/cea.12809. Epub 2016 Oct 14.

23.

Reduced sputum expression of interferon-stimulated genes in severe COPD.

Hilzendeger C, da Silva J, Henket M, Schleich F, Corhay JL, Kebadze T, Edwards MR, Mallia P, Johnston SL, Louis R.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 30;11:1485-94. doi: 10.2147/COPD.S105948. eCollection 2016.

24.

Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.

Jozwik A, Habibi MS, Paras A, Zhu J, Guvenel A, Dhariwal J, Almond M, Wong EH, Sykes A, Maybeno M, Del Rosario J, Trujillo-Torralbo MB, Mallia P, Sidney J, Peters B, Kon OM, Sette A, Johnston SL, Openshaw PJ, Chiu C.

Nat Commun. 2016 Mar 9;7:11011. doi: 10.1038/ncomms11011. No abstract available.

25.

An Innovative Model of a Home-Like Environment for People in Vegetative and Minimally Conscious States.

Zylberman R, Carolei A, Sacco S, Mallia P, Pistoia F.

Neurohospitalist. 2016 Jan;6(1):14-9. doi: 10.1177/1941874415596747.

26.

The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD.

Russell KE, Chung KF, Clarke CJ, Durham AL, Mallia P, Footitt J, Johnston SL, Barnes PJ, Hall SR, Simpson KD, Starkey MR, Hansbro PM, Adcock IM, Wiegman CH.

PLoS One. 2016 Jan 11;11(1):e0146102. doi: 10.1371/journal.pone.0146102. eCollection 2016.

27.

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.

Jozwik A, Habibi MS, Paras A, Zhu J, Guvenel A, Dhariwal J, Almond M, Wong EHC, Sykes A, Maybeno M, Del Rosario J, Trujillo-Torralbo MB, Mallia P, Sidney J, Peters B, Kon OM, Sette A, Johnston SL, Openshaw PJ, Chiu C.

Nat Commun. 2015 Dec 21;6:10224. doi: 10.1038/ncomms10224. Erratum in: Nat Commun. 2016;7:11011.

28.

The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Hewitt R, Farne H, Ritchie A, Luke E, Johnston SL, Mallia P.

Ther Adv Respir Dis. 2016 Apr;10(2):158-74. doi: 10.1177/1753465815618113. Epub 2015 Nov 26. Review.

29.

Pathogenesis of Viral Infection in Exacerbations of Airway Disease.

Ritchie AI, Farne HA, Singanayagam A, Jackson DJ, Mallia P, Johnston SL.

Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S115-32. doi: 10.1513/AnnalsATS.201503-151AW. Review.

30.

Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms.

Niespodziana K, Cabauatan CR, Jackson DJ, Gallerano D, Trujillo-Torralbo B, Del Rosario A, Mallia P, Valenta R, Johnston SL.

EBioMedicine. 2014 Nov 18;2(1):64-70. doi: 10.1016/j.ebiom.2014.11.012. eCollection 2015 Jan.

31.

Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.

Footitt J, Mallia P, Durham AL, Ho WE, Trujillo-Torralbo MB, Telcian AG, Del Rosario A, Chang C, Peh HY, Kebadze T, Aniscenko J, Stanciu L, Essilfie-Quaye S, Ito K, Barnes PJ, Elkin SL, Kon OM, Wong WS, Adcock IM, Johnston SL.

Chest. 2016 Jan;149(1):62-73. doi: 10.1378/chest.14-2637. Epub 2016 Jan 6.

32.

The influence of asthma control on the severity of virus-induced asthma exacerbations.

Jackson DJ, Trujillo-Torralbo MB, del-Rosario J, Bartlett NW, Edwards MR, Mallia P, Walton RP, Johnston SL.

J Allergy Clin Immunol. 2015 Aug;136(2):497-500.e3. doi: 10.1016/j.jaci.2015.01.028. Epub 2015 Mar 13. No abstract available.

33.

Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbations.

Jackson DJ, Glanville N, Trujillo-Torralbo MB, Shamji BW, Del-Rosario J, Mallia P, Edwards MJ, Walton RP, Edwards MR, Johnston SL.

Clin Infect Dis. 2015 May 15;60(10):1528-31. doi: 10.1093/cid/civ062. Epub 2015 Feb 2.

34.

Inhaled glucocorticoids and COPD exacerbations.

Singanayagam A, Johnston SL, Mallia P.

N Engl J Med. 2015 Jan 1;372(1):92-3. doi: 10.1056/NEJMc1413308. No abstract available.

35.

IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, Jerico Del-Rosario, Telcian AG, Nikonova A, Zhu J, Aniscenko J, Gogsadze L, Bakhsoliani E, Traub S, Dhariwal J, Porter J, Hunt D, Hunt T, Hunt T, Stanciu LA, Khaitov M, Bartlett NW, Edwards MR, Kon OM, Mallia P, Papadopoulos NG, Akdis CA, Westwick J, Edwards MJ, Cousins DJ, Walton RP, Johnston SL.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1373-82. doi: 10.1164/rccm.201406-1039OC.

36.

Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae.

Finney LJ, Ritchie A, Pollard E, Johnston SL, Mallia P.

Int J Chron Obstruct Pulmon Dis. 2014 Oct 13;9:1119-32. doi: 10.2147/COPD.S54477. eCollection 2014. Review.

37.

Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease.

Finney L, Berry M, Singanayagam A, Elkin SL, Johnston SL, Mallia P.

Lancet Respir Med. 2014 Nov;2(11):919-932. doi: 10.1016/S2213-2600(14)70169-9. Epub 2014 Sep 17. Review.

PMID:
25240963
38.

The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.

Molyneaux PL, Cox MJ, Willis-Owen SA, Mallia P, Russell KE, Russell AM, Murphy E, Johnston SL, Schwartz DA, Wells AU, Cookson WO, Maher TM, Moffatt MF.

Am J Respir Crit Care Med. 2014 Oct 15;190(8):906-13. doi: 10.1164/rccm.201403-0541OC.

39.

The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease—a systematic review.

Zwaans WA, Mallia P, van Winden ME, Rohde GG.

J Clin Virol. 2014 Oct;61(2):181-8. doi: 10.1016/j.jcv.2014.06.025. Epub 2014 Jul 4. Review.

PMID:
25066886
40.

Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand.

Tsoumakidou M, Tousa S, Semitekolou M, Panagiotou P, Panagiotou A, Morianos I, Litsiou E, Trochoutsou AI, Konstantinou M, Potaris K, Footitt J, Mallia P, Zakynthinos S, Johnston SL, Xanthou G.

J Allergy Clin Immunol. 2014 Oct;134(4):944-954.e8. doi: 10.1016/j.jaci.2014.05.045. Epub 2014 Jul 19.

PMID:
25051954
41.

Towards an ethical theory in disaster situations.

Mallia P.

Med Health Care Philos. 2015 Feb;18(1):3-11. doi: 10.1007/s11019-014-9584-7.

PMID:
25028162
42.

Bronchial platelet-activating factor receptor in chronic obstructive pulmonary disease.

Suri R, Mallia P, Martin JE, Footitt J, Zhu J, Trujillo-Torralbo MB, Johnston SL, Grigg J.

Respir Med. 2014 Jun;108(6):898-904. doi: 10.1016/j.rmed.2014.03.003. Epub 2014 Mar 18.

43.

CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations.

Rohde G, Message SD, Haas JJ, Kebadze T, Parker H, Laza-Stanca V, Khaitov MR, Kon OM, Stanciu LA, Mallia P, Edwards MR, Johnston SL.

Clin Exp Allergy. 2014 Jul;44(7):930-9. doi: 10.1111/cea.12313.

44.

Soluble major histocompatibility complex class I-related chain B molecules are increased and correlate with clinical outcomes during rhinovirus infection in healthy subjects.

Telcian AG, Zdrenghea MT, Caramori G, Laza-Stanca V, Message SD, Kebadze T, Kon OM, Groh V, Papi A, Johnston SL, Mallia P, Stanciu LA.

Chest. 2014 Jul;146(1):32-40. doi: 10.1378/chest.13-2247.

45.

IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection.

Jayaraman A, Jackson DJ, Message SD, Pearson RM, Aniscenko J, Caramori G, Mallia P, Papi A, Shamji B, Edwards M, Westwick J, Hansel T, Stanciu LA, Johnston SL, Bartlett NW.

Mucosal Immunol. 2014 Sep;7(5):1151-64. doi: 10.1038/mi.2014.2. Epub 2014 Jan 29.

46.

Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma.

Zhu J, Message SD, Qiu Y, Mallia P, Kebadze T, Contoli M, Ward CK, Barnathan ES, Mascelli MA, Kon OM, Papi A, Stanciu LA, Jeffery PK, Johnston SL.

Chest. 2014 Jun;145(6):1219-1229. doi: 10.1378/chest.13-1567.

47.

Experimental rhinovirus infection in COPD: implications for antiviral therapies.

Gunawardana N, Finney L, Johnston SL, Mallia P.

Antiviral Res. 2014 Feb;102:95-105. doi: 10.1016/j.antiviral.2013.12.006. Epub 2013 Dec 24. Review.

PMID:
24370732
48.

Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease.

Mallia P, Message SD, Contoli M, Gray K, Telcian A, Laza-Stanca V, Papi A, Stanciu LA, Elkin S, Kon OM, Johnson M, Johnston SL.

Respir Med. 2014 Jan;108(1):78-85. doi: 10.1016/j.rmed.2013.09.010. Epub 2013 Sep 22.

49.

Ethical aspects of vegetative and minimally conscious states.

Mallia P, Daniele R, Sacco S, Carolei A, Pistoia F.

Curr Pharm Des. 2014;20(26):4299-304. Review.

PMID:
24025065
50.

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, Moffatt MF, Johnston SL.

Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31. doi: 10.1164/rccm.201302-0341OC.

Supplemental Content

Loading ...
Support Center